Factor Xa inhibitor for venous thromboembolism management in patient with cancer: a systematic review and meta-analysis

Background: An earlier systematic review reported no differences in the incidence of recurrent venous thromboembolism and major bleeding between factor Xa inhibitors and standard anticoagulation. The present meta-analysis aimed to assess the effectiveness of factor Xa inhibitors for the management o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nugroho Eko Putranto, Johanes, Wardhana, Ardyan, Noor, Yoga Alfian, Lambok Marnala Yosua Siahaan, Pirhot, Al Farabi, Makhyan Jibril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802150/
https://www.ncbi.nlm.nih.gov/pubmed/35136585
http://dx.doi.org/10.12688/f1000research.73883.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802150/
https://www.ncbi.nlm.nih.gov/pubmed/35136585
http://dx.doi.org/10.12688/f1000research.73883.1

Ejemplares similares